The clinical significance of equivocal findings on spinal MRI in children with medulloblastoma

Medulloblastoma (MB) is the most common malignant brain tumor of childhood, with cerebrospinal fluid spread the most common site of metastasis. Currently, children diagnosed with MB and evidence of spinal metastasis are treated with an increased dose of craniospinal radiation (CSI). This report reviewed equivocal abnormalities including nerve root clumping, linear vascular enhancement, nerve root enhancement and/or other vague findings on spinal magnetic resonance imaging (MRI) to elucidate their prognostic significance and aid in risk stratification.

[1]  N. S. Grachev,et al.  [MRI diagnosis of spinal metastasis of medulloblastoma. A clinical case and literature review]. , 2015, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko.

[2]  E. Hattingen,et al.  Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. , 2014, Neurosurgical focus.

[3]  S. Rutkowski,et al.  Recent developments and current concepts in medulloblastoma. , 2014, Cancer treatment reviews.

[4]  David T. W. Jones,et al.  Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. , 2013, The Lancet. Oncology.

[5]  R. Tubbs,et al.  Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis , 2013, Child's Nervous System.

[6]  T. MacDonald,et al.  Medulloblastoma and primitive neuroectodermal tumors. , 2012, Handbook of clinical neurology.

[7]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[8]  Scott L. Pomeroy,et al.  Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples , 2011, Acta Neuropathologica.

[9]  Hendrik Witt,et al.  Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. R. Walsh,et al.  Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994–2003 , 2007, Child's Nervous System.

[11]  T. Merchant,et al.  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.

[12]  T. Merchant,et al.  Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Ditchfield,et al.  Correlation of MRI and CSF cytology in the diagnosis of medulloblastoma spinal metastases , 1998, Pediatric Radiology.

[14]  K. Sartor,et al.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1995, Neurosurgery.

[15]  S. Meyers,et al.  Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine. , 1994, AJNR. American journal of neuroradiology.

[16]  J. Atkinson,et al.  Enhanced lumbar nerve roots in the spine without prior surgery: radiculitis or radicular veins? , 1994, AJNR. American journal of neuroradiology.

[17]  J. Jinkins.  MR of enhancing nerve roots in the unoperated lumbosacral spine. , 1993, AJNR. American journal of neuroradiology.

[18]  P. Hudgins,et al.  Gadopentetate dimeglumine-enhanced MR imaging in children following surgery for brain tumor: spectrum of meningeal findings. , 1991, AJNR. American journal of neuroradiology.